These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 23516586)
21. The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study. Dajti E; Ravaioli F; Paiola G; Volpi S; Colecchia L; Ferrarese A; Alemanni LV; Cusumano C; Di Biase AR; Marasco G; Vestito A; Festi D; Rautou PE; Cipolli M; Colecchia A Liver Int; 2023 Nov; 43(11):2492-2502. PubMed ID: 37724776 [TBL] [Abstract][Full Text] [Related]
22. A pilot study of the characterization of hepatic tissue strain in children with cystic-fibrosis-associated liver disease (CFLD) by acoustic radiation force impulse imaging. Behrens CB; Langholz JH; Eiler J; Jenewein R; Naehrlich L; Fuchs K; Harth S; Krombach GA; Alzen GF Pediatr Radiol; 2013 Mar; 43(5):552-7. PubMed ID: 23192669 [TBL] [Abstract][Full Text] [Related]
23. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis. Issa Z; Gohy S; Zech F; Baldin P; Delire B; Dahlqvist G Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101977. PubMed ID: 35772685 [TBL] [Abstract][Full Text] [Related]
24. Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience. El-Faramawy A; Nasr SZ; Emam MMSA; Fahmy HMH Pediatr Pulmonol; 2024 Feb; 59(2):465-471. PubMed ID: 38038166 [TBL] [Abstract][Full Text] [Related]
25. Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: A 27-year real-life cohort study. Baldissera M; Lewindon PJ; Ramm LE; Hartel GF; Mattiello R; Ramm GA J Cyst Fibros; 2022 Mar; 21(2):230-235. PubMed ID: 34949555 [TBL] [Abstract][Full Text] [Related]
26. The natural history of cystic fibrosis liver disease a prospective cohort study. Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ; J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468 [TBL] [Abstract][Full Text] [Related]
27. 2D Shear Wave Elastography, a promising screening tool for Cystic Fibrosis liver disease, shows a correlation between vitamin D and liver stiffness. H E; Cr H; S D; Ea E J Cyst Fibros; 2022 Sep; 21(5):873-877. PubMed ID: 35794060 [TBL] [Abstract][Full Text] [Related]
28. Genetic modifiers of liver disease in cystic fibrosis. Bartlett JR; Friedman KJ; Ling SC; Pace RG; Bell SC; Bourke B; Castaldo G; Castellani C; Cipolli M; Colombo C; Colombo JL; Debray D; Fernandez A; Lacaille F; Macek M; Rowland M; Salvatore F; Taylor CJ; Wainwright C; Wilschanski M; Zemková D; Hannah WB; Phillips MJ; Corey M; Zielenski J; Dorfman R; Wang Y; Zou F; Silverman LM; Drumm ML; Wright FA; Lange EM; Durie PR; Knowles MR; JAMA; 2009 Sep; 302(10):1076-83. PubMed ID: 19738092 [TBL] [Abstract][Full Text] [Related]
29. The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study. Toledano MB; Mukherjee SK; Howell J; Westaby D; Khan SA; Bilton D; Simmonds NJ PLoS One; 2019; 14(4):e0212779. PubMed ID: 30947265 [TBL] [Abstract][Full Text] [Related]
30. Extended Screening for Cystic Fibrosis-related Liver Disease Including Elastography in Children and Adolescents. Højte C; Jørgensen MH; Jensen F; Katzenstein TL; Skov M J Pediatr Gastroenterol Nutr; 2020 Nov; 71(5):663-668. PubMed ID: 33093375 [TBL] [Abstract][Full Text] [Related]
31. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population. Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979 [TBL] [Abstract][Full Text] [Related]
32. Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis. Smith JL; Lewindon PJ; Hoskins AC; Pereira TN; Setchell KD; O'Connell NC; Shepherd RW; Ramm GA Hepatology; 2004 Jun; 39(6):1673-82. PubMed ID: 15185309 [TBL] [Abstract][Full Text] [Related]
33. Assessment of Liver Fibrosis with the Use of Elastography in Paediatric Patients with Diagnosed Cystic Fibrosis. Wiecek S; Fabrowicz P; Wos H; Kordys-Darmolinska B; Cebula M; Gruszczynska K; Grzybowska-Chlebowczyk U Dis Markers; 2022; 2022():4798136. PubMed ID: 35345868 [TBL] [Abstract][Full Text] [Related]
34. Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools. Scott JA; Jones AM; Jokl E; Gordon-Walker T; Barry PJ; Hanley NA; Piper Hanley K; Athwal VS Heliyon; 2023 Nov; 9(11):e21861. PubMed ID: 38053913 [TBL] [Abstract][Full Text] [Related]
35. Hepatic and Splenic Acoustic Radiation Force Impulse Shear Wave Velocity Elastography in Children with Liver Disease Associated with Cystic Fibrosis. Cañas T; Maciá A; Muñoz-Codoceo RA; Fontanilla T; González-Rios P; Miralles M; Gómez-Mardones G Biomed Res Int; 2015; 2015():517369. PubMed ID: 26609528 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease. El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620 [TBL] [Abstract][Full Text] [Related]